Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 96 Rectal Neoplasms 45 Colorectal Neoplasms 45 Carcinoma, Non-Small-Cell Lung 31 Esophageal Neoplasms 28 Esophageal Squamous Cell Carcinoma 24 Stomach Neoplasms 22 Lung Neoplasms 20 Pancreatic Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 18 Colonic Neoplasms 18 Sarcoma 16 Neoplasms 16 Adenocarcinoma Of Esophagus 15 Ovarian Neoplasms 14 Neoplasm Metastasis 14 Head and Neck Neoplasms 14 Carcinoma, Hepatocellular 14 Prostatic Neoplasms 13 Urinary Bladder Neoplasms 12 Uterine Cervical Neoplasms 10 Inflammatory Breast Neoplasms 9 Fallopian Tube Neoplasms 9 Osteosarcoma 8 Central Nervous System Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Kidney Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Recurrence 6 Multiple Myeloma 6

Interventions

Paclitaxel 95 Carboplatin 77 pembrolizumab 74 Cisplatin 29 Bevacizumab 27 Surveys and Questionnaires 23 Radiotherapy 22 Letrozole 22 Doxorubicin 21 Megestrol Acetate 20 olaparib 19 lenvatinib 19 Taxes 17 Specimen Handling 17 Docetaxel 17 Nivolumab 16 Magnetic Resonance Spectroscopy 16 dostarlimab 15 Metformin 15 Blood Specimen Collection 14 Observation 13 Gemcitabine 13 Biopsy 13 durvalumab 12 Medroxyprogesterone Acetate 12 Trastuzumab 11 Indocyanine Green 11 Fulvestrant 11 temsirolimus 10 abemaciclib 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Neoadjuvant Therapy × Clear all

NCT05179447 2025-04-01

PROBEAT

Women's Hospital School Of Medicine Zhejiang University

Phase NA Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡